文献速递药物不良反应与药物警戒药物相互作用治疗药物监测与药物基因组学

氯喹与阿奇霉素在健康志愿者中的药理学与心电图评价

Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers.
PubMed 文献 · Clin Pharmacol Ther · 2022-06-22

本研究基于119名健康成人随机分组(安慰剂、氯喹单用600mg基质、氯喹联合阿奇霉素500/1000/1500mg每日3天),利用群体药代动力学与心电图模型评估两药心脏效应。氯喹浓度依赖性地延长PR、QRS、JTc和QTc间期,阿奇霉素附加效应极小,QRS增宽贡献约28%的QT延长。两药无药物相互作用。

要点

  • 氯喹浓度依赖性地延长PR、QRS、JTc和QTc间期。
  • 阿奇霉素联合用药未显著增加氯喹的心电图效应。
  • QRS增宽贡献约28%的QT延长,提示TdP风险可能被高估。

核心结论

  • 氯喹导致浓度依赖性的心室去极化和复极化延迟,阿奇霉素联合给药未显著增加这些效应。
  • 未分离QRS和JT延长的研究可能高估了氯喹相关TdP风险。

研究设计与样本

  • 研究为在119名健康成人志愿者中进行的随机对照试验,设5个分组:安慰剂、氯喹单用600 mg基质、氯喹联合阿奇霉素500 mg、1000 mg或1500 mg,均每日给药3天。
  • 采用液相色谱-串联质谱法测定氯喹和阿奇霉素血药浓度,并频繁记录心电图间期。
  • 使用线性和非线性混合效应模型评估PR、QRS、心率校正JT和QT间期的时间匹配变化与血浆浓度的关系。

主要发现

  • 氯喹和阿奇霉素的药代动力学分别由二室和三室分布模型满意描述。
  • 未观察到氯喹与阿奇霉素之间的药物相互作用。
  • 氯喹浓度依赖性地延长PR、QRS、JTc和QTc间期,阿奇霉素仅有极小附加效应。
  • QRS增宽约占观察到的QT延长的28%。

临床怎么用

  • 临床使用氯喹时应关注浓度依赖性心电图改变,尤其是QRS和QT间期延长。
  • 与阿奇霉素联用时,心脏效应未见显著叠加,但仍需个体化评估风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chloroquine and azithromycin were developed in combination for the preventive treatment of malaria in pregnancy, and more recently were proposed as coronavirus disease 2019 (COVID-19) treatment options. Billions of doses of chloroquine have been administered worldwide over the past 70 years but concerns regarding cardiotoxicity, notably the risk of torsades de pointes (TdP), remain. This investigation aimed to characterize the pharmacokinetics and electrocardiographic effects of chloroquine and azithromycin observed in a large previously conducted healthy volunteer study. Healthy adult volunteers (n = 119) were randomized into 5 arms: placebo, chloroquine alone (600 mg base), or chloroquine with either 500 mg, 1,000 mg, or 1,500 mg of azithromycin all given daily for 3 days. Chloroquine and azithromycin levels, measured using liquid-chromatography tandem mass spectrometry, and electrocardiograph intervals were recorded at frequent intervals. Time-matched changes in the PR, QRS, and heart rate-corrected JT, and QT intervals were calculated and the relationship with plasma concentrations was evaluated using linear and nonlinear mixed-effects modeling. Chloroquine and azithromycin pharmacokinetics were described satisfactorily by two- and three-compartment distribution models, respectively. No drug-drug interaction between chloroquine and azithromycin was observed. Chloroquine resulted in concentration-dependent prolongation of the PR, QRS, JTc and QTc intervals with a minimal additional effect of azithromycin. QRS widening contributed ~ 28% of the observed QT prolongation. Chloroquine causes significant concentration-dependent delays in both ventricular depolarization and repolarization. Co-administration of azithromycin did not significantly increase these effects. The arrhythmogenic risk of TdP associated with chloroquine may have been substantially overestimated in studies which did not separate electrocardiograph QRS and JT prolongation.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Chotsiri P, Tarning J, Hoglund RM, et al. Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers. Clin Pharmacol Ther. 2022. PMID: 35598114. doi:10.1002/cpt.2665

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。